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International travel is a known risk factor for intestinal colonization with extended-spectrum 
cephalosporin-resistant (ESC-R) Enterobacteriaceae [1], thereby contributing to their spread from 
high to low endemicity countries like Switzerland. This phenomenon is also observed in military 
personnel stationed in high endemicity areas. For instance, French soldiers deployed to 
Afghanistan and Côte d’Ivoire showed colonization rates with ESC-R Escherichia coli >50% [2]. 
In Switzerland, military personnel have been deployed for peacekeeping missions to various 
regions for decades.  
In the present study, the extent of intestinal colonization with ESC-R- and/or colistin-
resistant (COL-R) Enterobacteriaceae in military staff deployed to Kosovo from November 2017 
to April 2018 was analyzed. Stools were collected before and after the service (within one week). 
As previously done, samples were enriched overnight in Luria-Bertani broth containing 
cefuroxime (3 mg/L) or colistin (2 mg/L). From each tube, aliquots were plated on ChromID 
ESBL/Carba (bioMérieux) or CHROMagar Orientation plus colistin (4 mg/L) and vancomycin (8 
mg/L), respectively, and incubated overnight [3]. At least five colonies were selected from each 
positive agar plate for further analyses. Species identification was achieved using the MALDI-
TOF MS (Bruker). MICs for antibiotics were obtained implementing the Sensititre GNX2F 
microdilution plates and interpreted using the 2019 European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) criteria (www.eucast.org). Whole-genome sequencing was 
performed with NovaSeq 6000 (Illumina) and reads were analyzed using the tools of the Center 
for Genomic Epidemiology (CGE; www.genomicepidemiology.org/) [1, 3].  
Both pre- and post-deployment stools were available for 21 participants. As shown in Table 
1, two subjects were already colonized with COL-R E. coli strains before going to Kosovo: one 
carried the mcr-1.2 gene in a 33kb IncX4 plasmid that is frequently reported worldwide (data not 
shown) [3], while the other one showed amino acid substitutions in the chromosomal PmrA/B 
two-component system. Upon return to Switzerland, three (14.3%) deployed persons (including 
one earlier colonized with the mcr-1.2-positive strain) screened positive for ESC-R E. coli. Such 
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strains were of different STs (ST2540, ST69, and ST484) not belonging to hyperepidemic 
lineages, and all carried the blaCTX-M-15 along with other antimicrobial resistance genes 
(Supplementary File S1). Strains with reduced susceptibility to colistin, carbapenems and/or 
fluoroquinolones were not detected (Table 1).  
The gut colonization prevalence with ESC-R Enterobacteriaceae recorded in the present 
study was similar to the one found in a study involving German soldiers deployed internationally 
between 2007-2015 (4.7%) and among French soldiers sent to French Guiana during 2012 (5.3%) 
[2, 4]. However, it was considerably lower than the incidence among French army persons 
returning from Côte d’Ivoire and Afghanistan (49% and 88%, respectively) in 2012 [2].  
Based on our results, we speculate that the recorded colonization rates in soldiers returning to 
their home countries do not fully mirror the prevalence of antimicrobial resistance in the region 
of deployment. Unfortunately, data on colonization rates with ESC-R E. coli in the local 
population in Kosovo are not available. However, in 2017 the surrounding regions in Eastern and 
South Eastern Europe showed up to 40% of E. coli from clinical samples to be ESC-R 
(https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2017).  
This is much higher than the 10% found in Switzerland during the same time period 
(www.anresis.ch). Therefore, colonization rates in military personnel returning from Kosovo 
could have been predicted to be much higher than the 14% actually found in our participants. 
This unexpected low colonization rate in the Swiss military personnel could have several reasons. 
It is possible that Kosovo has overall lower resistance rates than the neighboring countries. More 
likely, the low rates found in these subjects could be due to their different hygienic conditions 
compared to the local population, thus preventing them from acquiring multidrug-resistant 
bacteria from food chain, animals, and/or environment. Looking at our participants, we note for 
instance that half of them ate more than 50% of their meals inside the military compound (Table 
1). This behavior is very different to what is observed in travelers visiting tropical and subtropical 
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countries who show considerably higher rates of gut colonization due to their closer contact and 
more frequent interaction with the local human and non-human settings [1].   
Our data indicate that deployment-related colonization rates with ESC-R E. coli are slightly 
higher than those recorded in the healthy population in Switzerland (~7%) [5], but considerably 
lower than those observed in international travelers (up to 75%) [1]. Therefore, the impact of 
military personnel returning from international deployment on the spread of antimicrobial 
resistance is probably less important than that of travelers. Nevertheless, larger studies assessing 
military personnel returning from different countries need to be carried out to properly assess the 
impact of these subjects on the worldwide spread of antimicrobial resistance. 
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Table 1. Demographic data of participants, colonization status before and after travelling, and characteristics (phenotypic 
and molecular) of recovered strains 
ID Age Sex 
Phenotypic and molecular characteristics of ESC- and/or 
COL-R strains (if any) a 
Potential risk factors during deployment 
Stools collected before 
deployment 
Stools collected after 
deployment 
Antibiotic 
use 
Hospitalization Diarrhea 
Food 
outside 
military 
compound 
(times/week) 
ID6 24 M Negative Negative no no no 7 
ID10 26 M Negative Negative no no yes 6 
ID12 27 M Negative Negative no no yes 1 
ID13 31 M Negative Negative no no yes 1 
ID22 47 M Negative Negative na na na na 
ID25 25 F E. coli: COL (4), CTX (≤1), 
FEP (≤2), MEM (≤1), CIP (1), 
CN (≤1), DOX (8), SXT (4) 
ST69-like; mcr-1.2, blaTEM-1B, 
aph(3’’)-Ib, aph(6)-Id, aadA1, 
aadA2, mdf(A), cmlA1, sul2, 
sul3, tet(A), dfrA5, GyrA 
(S83L), ParC (S80R), [PmrB: 
H2R, S138N, D283G]; 
Col440II, FIB, FII, Q1, X1, 
X4 
E. coli: COL (≤0.25), CTX 
(16), FEP (≤2), MEM (≤1), 
CIP (≤0.25), CN (≤1), DOX 
(4), SXT (1) 
ST2540; blaCTX-M-15, aadA5, 
mdf(A), tet(A), dfrA17, [PmrB: 
D283G, Y358N]; FII, FIA, 
FIB, HI1A, HI1B 
na na na na 
ID26 25 F Negative Negative na na na na 
ID29 49 F Negative E. coli: COL (≤0.25), CTX 
(16), FEP (≤2), MEM (≤1), 
CIP (≤0.25), CN (≤1), DOX 
(≤2), SXT (≤0.5) 
ST69; blaCTX-M-15, qnrS1, 
mdf(A), [PmrB: H2R, S138N, 
D283G]; FII, X4 
no no yes 3 
ID30 29 F Negative Negative no no yes 7 
ID31 33 F Negative Negative yes no no 7 
ID34 27 M Negative Negative no no yes 1 
ID37 32 M Negative Negative no no no 0 
ID38 31 F Negative Negative no no yes 1 
ID39 30 F Negative E. coli: COL (≤0.25), CTX 
(32), FEP (≤2), MEM (≤1), 
CIP (≤0.25), CN (≤1), DOX 
(≤2), SXT (≤0.5) 
ST484; blaCTX-M-15, qnrS1, 
mdf(A); FIC 
no no no 7 
ID40 29 F Negative Negative yes no 1 na 
ID42 28 F E. coli: COL (>4), CTX (≤1), 
FEP (≤2), MEM (≤1), CIP 
(≤0.25), CN (≤1), DOX (≤2), 
SXT (≤0.5) 
ST420-like; mdf(A), [PmrA: 
T31S, I128N, G144S, ; PmrB: 
H2R, E123D, T156K, D283G, 
V351I]; Col156, FIB, FII 
Negative no no yes 1 
ID64 26 M Negative Negative na na na na 
ID65 25 M Negative Negative no no yes 3 
ID66 23 M Negative Negative no no no 1 
ID69 29 M Negative Negative no no 1 0 
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ID70 28 M Negative Negative no no no 4 
Note. M, male; F, female; na, not available; COL, colistin; CTX, cefotaxime; FEP, cefepime; MEM, meropenem; CIP, 
ciprofloxacin; CN, gentamicin; DOX, doxycycline, SXT, trimethoprim-sulfamethoxazole  
a We show: bacterial species with antimicrobial phenotype (MIC, mg/L), sequence type (ST), antimicrobial resistance 
genes, and replicon type plasmid detected by WGS and implementing the CGE analysis. Among the unknown mutations 
(according to the CGE analysis), only those for pmrA and pmrB have been reported in square parentheses (as amino acid 
substitutions) 
